Microbial Novoteqs

Microbial Novoteqs is a biotechnology company based in Nashville, Tennessee, specializing in the development of microbial cell-based assays and platforms for drug discovery. The company utilizes a proprietary platform featuring engineered yeast strains (Saccharomyces cerevisiae) to identify and evaluate inhibitors of viral proteases through cell-growth phenotypes. This technology enables the rapid and cost-effective screening of drug candidates for membrane permeability and non-toxicity at the initial discovery stage. Microbial Novoteqs focuses on infectious and neglected diseases, with research programs targeting SARS-CoV, HIV, Hepatitis C, and Norwalk virus. The company has received significant funding from the National Institutes of Health (NIH) and operates within the Cumberland Emerging Technologies Life Sciences Center.